<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00992043</url>
  </required_header>
  <id_info>
    <org_study_id>eefeusp2</org_study_id>
    <nct_id>NCT00992043</nct_id>
  </id_info>
  <brief_title>Creatine Supplementation and Diabetes</brief_title>
  <official_title>Efficacy and Safety of Creatine Supplementation Combined With Exercise Training in Type 2 Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The
      researchers aim to investigate whether this supplement can affect metabolic control in
      diabetic patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glycated hemoglobin</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Diabetes</condition>
  <condition>Renal Function</condition>
  <arm_group>
    <arm_group_label>exercise and placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>exercise and creatine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>creatine</intervention_name>
    <arm_group_label>exercise and placebo</arm_group_label>
    <arm_group_label>exercise and creatine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <arm_group_label>exercise and placebo</arm_group_label>
    <arm_group_label>exercise and creatine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males and females type 2 diabetic patients

          -  glycated hemoglobin between &gt; 9%

          -  non insulin users

          -  physically inactive

          -  only metformin and/or sulfonylurea users

          -  BMI &gt; 30 kg/m2

          -  age of years &gt; 50 y
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Gualano, PhD ongoing</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Hospital - School of Medicine - University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>March 22, 2010</last_update_submitted>
  <last_update_submitted_qc>March 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bruno Gualano</name_title>
    <organization>University of Sao Paulo</organization>
  </responsible_party>
  <keyword>creatine supplementation</keyword>
  <keyword>exercise training</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

